 |
ProductsAntisoma has a diverse portfolio of products in development. Our products target tumours by several different mechanisms and are intended for the treatment of a range of cancers. 
Read more
|
Latest news
| 02/02/2010 | Antisoma to present at BIO CEO Conference | |
| 07/01/2010 | Antisoma to present at J.P. Morgan Healthcare Conference | |
| 16/12/2009 | AS1411 shows activity in kidney cancer but AML remains priority |
In focus
|
14/01/10 - Latest corporate presentation | |
|
14/09/09 - Preliminary results presentation |
Share price
| 33.75 GBp |  -1.25 |
| Date: | 08/02/2010 |
